VRDN

Bullish

Viridian Therapeutics (VRDN) Prices Upsized Concurrent Public Offerings Totaling $350M

Viridian Therapeutics (NASDAQ: VRDN) has priced upsized concurrent public offerings totaling $350 million. The financing includes $225 million in 1.75...

Insider Monkey 4 days ago 0

Neutral

Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stock

Viridian Therapeutics has commenced concurrent public offerings of $150.0 million in convertible senior notes due 2032 and $100.0 million in common st...

BioSpace 2 weeks ago 0